Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status

Wei Zheng; Jingfeng Zong; Chaobin Huang; Juhui Chen; Junxin Wu; Chuanben Chen; Shaojun Lin; Jianji Pan

doi:10.1371/journal.pone.0146771

Loading metrics

Open Access

Peer-reviewed

Research Article

Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status

Wei Zheng ,

Contributed equally to this work with: Wei Zheng, Jingfeng Zong

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Jingfeng Zong ,

Contributed equally to this work with: Wei Zheng, Jingfeng Zong

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Chaobin Huang,

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Juhui Chen,

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Junxin Wu,

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Chuanben Chen,

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Shaojun Lin,

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯
Jianji Pan

* E-mail: panjianji@126.com

Affiliations Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, Fujian 350014, People’s Republic of China, Fujian Provincial Key Laboratory of Translational Cancer Medicine (Fujian Provincial Cancer Hospital, Fujian Medical University Union Hospital), Fuzhou, Fujian 350014, People’s Republic of China
⨯

Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status

Wei Zheng,
Jingfeng Zong,
Chaobin Huang,
Juhui Chen,
Junxin Wu,
Chuanben Chen,
Shaojun Lin,
Jianji Pan

Published: January 12, 2016
https://doi.org/10.1371/journal.pone.0146771

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.
Nasopharyngeal carcinoma
Is the Subject Area "Nasopharyngeal carcinoma" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Palliative care
Is the Subject Area "Palliative care" applicable to this article?

Thanks for your feedback.